Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2010
03/30/2010US7687615 PAV regions for encapsidation and E1 transcriptional control
03/30/2010US7687613 gene transfer vector comprising a humanized nucleic acid sequence encoding an immunogenic portion of one or more exotoxins of Bacillus anthracis and a heterologous sorting signal
03/30/2010US7687474 Nitroreductase enzymes
03/30/2010US7687070 Reagents for intracellular delivery of macromolecules
03/30/2010US7687058 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
03/30/2010US7687057 In vitro micro-organs, and uses related thereto
03/30/2010CA2433069C Latent human tuberculosis model, diagnostic antigens, and methods of use
03/30/2010CA2292792C Recombinant adenoviral vectors comprising a splicing sequence
03/30/2010CA2263765C Methods for the production of protein particles useful for delivery of pharmacological agents
03/30/2010CA2174652C Nucleotide vector, composition containing such vector and vaccine for immunization against hepatitis
03/30/2010CA2144223C Effector proteins of rapamycin
03/25/2010WO2010034006A2 The putative tumor suppressor microrna-101 modulates the cancer epigenome by repressing the polycomb group protein ezh2.
03/25/2010WO2010033871A2 Compositions and methods targeting glutaminase
03/25/2010WO2010033580A2 Curcumin conjugates for treating and preventing cancers
03/25/2010WO2010033560A2 Sur1 inhibitors for therapy
03/25/2010WO2010033225A2 Compositions and methods for the specific inhibition of gene expression by dsrna possessing modifications
03/25/2010WO2010033167A2 Anti-thrombin aptamer formulations and methods for use
03/25/2010WO2010032786A1 Transgenic animal
03/25/2010WO2010032696A1 Diagnosis method and therapeutic method for cancer
03/25/2010WO2010012088A8 Soluble igf receptors as anti-angiogenic agents
03/25/2010WO2010004283A3 Sulfonylurea receptor and means for treating ischaemia
03/25/2010WO2009149418A3 Compositions for the in vivo delivery of rnai agents
03/25/2010US20100075869 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)
03/25/2010US20100075423 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
03/25/2010US20100075378 Moraxella catarrhalis basb115 polypeptides
03/25/2010US20100074946 Process for preparing purified nucleic acid and the use thereof
03/25/2010US20100074919 Circovirus sequences associated with piglet weight loss disease (PWD)
03/25/2010CA2738625A1 Compositions and methods for the specific inhibition of gene expression by dsrna possessing modifications
03/25/2010CA2737212A1 Dendritic cell modulatory molecule
03/24/2010EP2166095A2 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes in endothelial cells
03/24/2010EP2166093A1 Pharmaceutical composition for enzyme replacement therapy
03/24/2010EP2166019A2 Immunisation against Chlamydia Pneumoniae
03/24/2010EP2166017A1 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
03/24/2010EP2165605A1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation
03/24/2010EP2164964A1 Dehydrated chitosan nanoparticles
03/24/2010EP1075496B1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
03/24/2010CN101679962A Single-stranded cyclic rna, and method for production thereof
03/24/2010CN101678126A Meganuclease variants cleaving a DNA target sequence from the beta-2-microglobulin gene and uses thereof
03/24/2010CN101678117A Methods and compositions for gene therapy
03/24/2010CN101678087A Obligate heterodimer meganucleases and uses thereof
03/24/2010CN101676391A A system capable of stably expressing cell cycle factor FoxM1 and its medical use
03/24/2010CN101676389A Modified vaccinia ankara virus variant
03/24/2010CN101675992A Beta-amyloid-analogue-t-cell epitop vaccine
03/24/2010CN100594931C The pIFN-gamma gene adjuvant for pig vaccine and its prepn process
03/23/2010US7683236 Enhanced production of cloned mammals by zona pellucida-free homologous mammalian embryo aggregation
03/23/2010US7683164 Nucleic acid derivatives
03/23/2010US7683038 Such as gellan, carboxymethylcellulose, pectic acid, pectin and hyaluronic acid derivativesl; for use in the pharmaceutical, biomedical, surgical and healthcare fields
03/23/2010US7683036 especially nucleic acid and nucleic acid-like oligomers, which are targeted to or mimic nucleic acids comprising or encoding small non-coding RNAs, and which act to modulate the levels of small non-coding RNAs, or interfere with their function
03/23/2010US7682787 Using UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (GalNAc-T3) to identify modulators for prevention and treatment of familial tumoral calcinosis (FTC)
03/23/2010US7682626 Polyvinylethers for delivery of polynucleotides to mammalian cells
03/23/2010CA2305312C Mammalian genes involved in viral infection and tumor suppression
03/23/2010CA2223412C Method for prolonging the expression of a gene of interest using soluble ctla4 molecules
03/23/2010CA2203655C Tumor necrosis factor-gamma
03/23/2010CA2194797C Nucleic acid containing composition, preparation and uses of same
03/18/2010WO2010030980A2 Akt and clusterin as biomarkers of chemotherapeutic responsiveness
03/18/2010WO2010030963A2 Modulation of bcl11a for treatment of hemoglobinopathies
03/18/2010WO2010030936A2 Novel autophagy regulators atg14l and rubicon
03/18/2010WO2010030751A2 New modalities for treatment of drug-resistant tuberculosis and other diseases
03/18/2010WO2010030396A2 Novel shrna gene therapy for treatment of ischemic heart disease
03/18/2010WO2010030002A1 Cell capable of expressing exogenous gitr ligand
03/18/2010WO2010029297A1 Photo-ionic pacemakers
03/18/2010WO2009140649A8 Rab3b for the treatment and prevention of parkinson's disease
03/18/2010WO2009135180A3 A method for generating reference controls for pharmacogenomic testing
03/18/2010WO2009078012A3 Methods of generating expanded and re-differentiated adult islet beta cells for use in the treatment of diabetes
03/18/2010US20100069466 Compositions and Methods for the Systemic Treatment of Arthritis
03/18/2010US20100069465 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
03/18/2010US20100068281 Methods and compositions for tissue regeneration
03/18/2010US20100068261 Methods and compositions for the production of monoclonal antibodies
03/18/2010US20100068241 Reconstituted mineralized cartilage tissue
03/18/2010US20100068208 Degranulation inhibitor
03/18/2010US20100068202 Method of treating hemolytic disease
03/18/2010US20100068201 Compositions and methods for the systemic treatment of arthritis
03/18/2010US20100068200 Methods and Compositions for Inhibiting Atherosclerosis and Vascular Inflammation
03/18/2010US20100068177 Methods of organ regeneration
03/18/2010US20100068141 Use of heat shock to treat ocular disease
03/18/2010CA2737180A1 Modulation of bcl11a for treatment of hemoglobinopathies
03/17/2010EP2163643A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
03/17/2010EP2163642A1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis
03/17/2010EP2163640A1 Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus
03/17/2010EP2163626A1 Human FGF-21 gene and gene expression products
03/17/2010EP2163260A2 Chimpanzee adenovirus vaccine carriers
03/17/2010EP2163258A1 Preventive/remedy for cancer
03/17/2010EP2163239A1 Products containing bioparticles, method for their manufacture
03/17/2010EP2162536A1 Targeted provision of recombinase activity by trans-splicing
03/17/2010EP2162534A1 Cd34 stem cell-related methods and compositions
03/17/2010EP1556493B1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof
03/17/2010EP1303536B1 Novel fibroblast growth factor (fgf23) and methods for use
03/17/2010CN101674853A Amino acid lipids and uses thereof
03/17/2010CN101674810A Targeting agent for cancer cell or cancer-associated fibroblast
03/17/2010CN101674809A Self-precipitating pharmaceutical formulations for the modified release of active principle
03/17/2010CN101671690A Recombinant expression carrier containing schistosoma japonicum gene and application thereof
03/17/2010CN101671689A Recombinant expression carrier containing schistosoma japonicum gene and application thereof
03/17/2010CN101671679A Resistance-relevant gene and applications of radiation-resistant cocci
03/17/2010CN101671673A Mice tyrosine hydrozylase promoter and recombination expression vector thereof
03/17/2010CN101671670A Hepatocellular carcinoma targeting gene expression element AP and applications thereof
03/17/2010CN101671669A Hepatocellular carcinoma targeting gene expression element AE and applications thereof
03/17/2010CN101671668A Hepatocellular carcinoma targeting gene expression element AG and applications thereof
03/17/2010CN101671666A Proliferation and tumor cell specific gene operating system for gene therapy of malignant tumor
03/17/2010CN101671397A Anti-EGFR single-chain antibody fusion Gelonin recombination immunotoxin, preparation method and usage thereof
03/17/2010CN101670119A polynucleotide
1 ... 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 ... 870